Literatur
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M et al (2017) Durvalumab after Chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 377:1919–1929
Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J, Prophylactic Cranial Irradiation Overview Collaborative Group (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341:476–484
Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 10:1037–1044
De Ruysscher D, Dingemans A‑MC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E et al (2018) Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: A randomized phase III NVALT-11/DLCRG-02 study. J Clin Oncol 36:2366–2377
Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A et al (2009) Standard-dose versus higher-dose Prophylactic Cranial Irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial. Lancet Oncol 10:467–474
Oehlke O, Wucherpfennig D, Fels F, Frings L, Egger K, Weyerbrock A, Prokic V, Nieder C, Grosu A‑L (2015) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival. Strahlenther Onkol 191:461–469
Pöttgen C, Eberhardt W, Grannass A, Korfee S, Stüben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H et al (2007) Prophylactic cranial irradiation in operable stage III A non small-cell lung cancer treated with neo adjuvant chemo radiotherapy: Results from a German multicenter randomized trial. J Clin Oncol 25(31):4987–4992. https://doi.org/10.1200/jco.2007.12.5468
Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu A‑L (2013) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: A planning study on treatment concepts. Int J Radiat Oncol Biol Phys 85:264–270
Russell AH, Pajak TE, Selim HM, Paradelo JC, Murray K, Bansal P, Cooper JD, Silverman S, Clement JA (1991) Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 21:637–643
Tsakonas G, De Petris L, Ekman S (2017) Management of brain metastasized non-small cell lung cancer (NSCLC) – From local treatment to new systemic therapies. Cancer Treat Rev 54:122–131
Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Aoyama H (2017) A multi-institutional prospective observational study of Stereotactic Radiosurgery for patients with multiple brain metastases (JLGK0901 study update): Irradiation-related complications and long-term maintenance of mini-mental state examinationscores. Int J Radiat Oncol Biol Phys 99:31–40
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Schmidt, S. Appold und E.G.C. Troost geben an, dass kein Interessenkonflikt besteht.
Additional information
Originalpublikation
De Ruysscher D, Dingemans A‑MC, Praag J et al (2018) Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT-11/DLCRG-02 study. J ClinOncol 36:2366–2377
Rights and permissions
About this article
Cite this article
Schmidt, J., Appold, S. & Troost, E.G.C. Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom. Strahlenther Onkol 195, 453–456 (2019). https://doi.org/10.1007/s00066-019-01443-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-019-01443-8